{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:12:03Z","timestamp":1790385123701,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41390-018-0089-6","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T10:16:25Z","timestamp":1530872185000},"page":"333-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Caffeine: an evidence-based success story in VLBW pharmacotherapy"],"prefix":"10.1038","volume":"84","author":[{"given":"Nicole R.","family":"Dobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"89_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1542\/peds.2005-0620H","volume":"117","author":"NN Finer","year":"2006","unstructured":"Finer, N. N., Higgins, R., Kattwinkel, J. & Martin, R. J. Summary proceedings from the apnea-of-prematurity group. Pediatrics 117, S47\u2013S51 (2006).","journal-title":"Pediatrics"},{"key":"89_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2016.11.081","volume":"182","author":"RS Horne","year":"2017","unstructured":"Horne, R. S. et al. The longitudinal effects of persistent apnea on cerebral oxygenation in infants born preterm. J. Pediatr. 182, 79\u201384 (2017).","journal-title":"J. Pediatr."},{"key":"89_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/adc.48.5.404","volume":"48","author":"JA Kuzemko","year":"1973","unstructured":"Kuzemko, J. A. & Paala, J. Apnoeic attacks in the newborn treated with aminophylline. Arch. Dis. Child 48, 404\u2013406 (1973).","journal-title":"Arch. Dis. Child"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1542\/peds.55.5.589","volume":"55","author":"DC Shannon","year":"1975","unstructured":"Shannon, D. C. et al. Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics 55, 589\u2013594 (1975).","journal-title":"Pediatrics"},{"key":"89_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.55.5.595","volume":"55","author":"R Uauy","year":"1975","unstructured":"Uauy, R., Shapiro, D. L., Smith, B. & Warshaw, J. B. Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics 55, 595\u2013598 (1975).","journal-title":"Pediatrics"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0022-3476(77)80718-X","volume":"90","author":"JV Aranda","year":"1977","unstructured":"Aranda, J. V., Gorman, W., Bergsteinsson, H. & Gunn, T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J. Pediatr. 90, 467\u2013472 (1977).","journal-title":"J. Pediatr."},{"key":"89_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","volume":"94","author":"JV Aranda","year":"1979","unstructured":"Aranda, J. V. et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J. Pediatr. 94, 663\u2013668 (1979).","journal-title":"J. Pediatr."},{"key":"89_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt, B. et al. Caffeine therapy for apnea of prematurity. N. Engl. J. Med 354, 2112\u20132121 (2006).","journal-title":"N. Engl. J. Med"},{"key":"89_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamapediatrics.2014.2965","volume":"169","author":"L Costantini","year":"2015","unstructured":"Costantini, L., D\u2019Ilario, J., Moddemann, D., Penner, K. & Schmidt, B. Accuracy of Bayley scores as outcome measures in trials of neonatal therapies. JAMA Pediatr. 169, 188\u2013189 (2015).","journal-title":"JAMA Pediatr."},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2165\/00128072-200305030-00006","volume":"5","author":"V Bhatt-Mehta","year":"2003","unstructured":"Bhatt-Mehta, V. & Schumacher, R. E. Treatment of apnea of prematurity. Paediatr. Drugs 5, 195\u2013210 (2003).","journal-title":"Paediatr. Drugs"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/neo.14-11-e540","volume":"14","author":"NR Dobson","year":"2013","unstructured":"Dobson, N. R. & Hunt, C. E. Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. Neoreviews 14, e540\u2013e550 (2013).","journal-title":"Neoreviews"},{"key":"89_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A. & Zvartau, E. E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83\u2013133 (1999).","journal-title":"Pharmacol. Rev."},{"key":"89_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.earlhumdev.2015.06.007","volume":"91","author":"V Parikka","year":"2015","unstructured":"Parikka, V. et al. The effect of caffeine citrate on neural breathing pattern in preterm infants. Early Human. Dev. 91, 565\u2013568 (2015).","journal-title":"Early Human. Dev."},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0378-3782(81)90071-2","volume":"5","author":"H Rigatto","year":"1981","unstructured":"Rigatto, H., Desai, U., Leahy, F., Kalapesi, Z. & Cates, D. The effect of 2% CO2, 100% O2, theophylline and 15% O2 on \u201cinspiratory drive\u201d and \u201ceffective\u201d timing in preterm infants. Early Hum. Dev. 5, 63\u201370 (1981).","journal-title":"Early Hum. Dev."},{"key":"89_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0095-5108(18)30748-6","volume":"14","author":"F Marchal","year":"1987","unstructured":"Marchal, F., Bairam, A. & Vert, P. Neonatal apnea and apneic syndromes. Clin. Perinatol. 14, 509\u2013529 (1987).","journal-title":"Clin. Perinatol."},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0006-8993(90)90925-2","volume":"516","author":"E Dux","year":"1990","unstructured":"Dux, E., Fastbom, J., Ungerstedt, U., Rudolphi, K. & Fredholm, B. B. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516, 248\u2013256 (1990).","journal-title":"Brain Res"},{"key":"89_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0014-2999(98)00559-7","volume":"357","author":"H Goda","year":"1998","unstructured":"Goda, H. et al. Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist. Eur. J. Pharmacol. 357, 149\u2013155 (1998).","journal-title":"Eur. J. Pharmacol."},{"key":"89_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0165-6147(92)90141-R","volume":"13","author":"KA Rudolphi","year":"1992","unstructured":"Rudolphi, K. A., Schubert, P., Parkinson, F. E. & Fredholm, B. B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439\u2013445 (1992).","journal-title":"Trends Pharmacol. Sci."},{"key":"89_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0022-3476(87)80569-3","volume":"110","author":"A Bairam","year":"1987","unstructured":"Bairam, A., Boutroy, M. J., Badonnel, Y. & Vert, P. Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant. J. Pediatr. 110, 636\u2013639 (1987).","journal-title":"J. Pediatr."},{"key":"89_CR20","first-page":"698","volume":"139","author":"C Brouard","year":"1985","unstructured":"Brouard, C. et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am. J. Dis. Child 139, 698\u2013700 (1985).","journal-title":"Am. J. Dis. Child"},{"key":"89_CR21","doi-asserted-by":"crossref","unstructured":"Henderson-Smart D. J. & De Paoli, A. G. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst. Rev. CD000140 (2010).","DOI":"10.1002\/14651858.CD000140.pub2"},{"key":"89_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/adc.67.4_Spec_No.425","volume":"67","author":"JE Scanlon","year":"1992","unstructured":"Scanlon, J. E. et al. Caffeine or theophylline for neonatal apnoea? Arch. Dis. Child 67, 425\u2013428 (1992).","journal-title":"Arch. Dis. Child"},{"key":"89_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1440-1754.2009.01570.x","volume":"45","author":"M Skouroliakou","year":"2009","unstructured":"Skouroliakou, M., Bacopoulou, F. & Markantonis, S. L. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial. J. Paediatr. Child Health 45, 587\u2013592 (2009).","journal-title":"J. Paediatr. Child Health"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jpeds.2013.12.025","volume":"164","author":"NR Dobson","year":"2014","unstructured":"Dobson, N. R. et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J. Pediatr. 164, 992 (2014).","journal-title":"J. Pediatr."},{"key":"89_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF00442697","volume":"147","author":"HU Bucher","year":"1988","unstructured":"Bucher, H. U. & Duc, G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial. Eur. J. Pediatr. 147, 288\u2013291 (1988).","journal-title":"Eur. J. Pediatr."},{"key":"89_CR26","doi-asserted-by":"crossref","unstructured":"Henderson-Smart D. J. & De Paoli, A. G. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst. Rev. CD000432 (2010).","DOI":"10.1002\/14651858.CD000432.pub2"},{"key":"89_CR27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/NPM-1371013","volume":"6","author":"EG Abu Jawdeh","year":"2013","unstructured":"Abu Jawdeh, E. G. et al. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists. J. Neonatal Perinat. Med 6, 251\u2013256 (2013).","journal-title":"J. Neonatal Perinat. Med"},{"key":"89_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.pedneo.2015.10.007","volume":"57","author":"AM Armanian","year":"2016","unstructured":"Armanian, A. M., Iranpour, R., Faghihian, E. & Salehimehr, N. Caffeine administration to prevent apnea in very premature infants. Pediatr. Neonatol. 57, 408\u2013412 (2016).","journal-title":"Pediatr. Neonatol."},{"key":"89_CR29","doi-asserted-by":"crossref","unstructured":"Henderson-Smart D. J. & Davis P. G. Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst. Rev. CD000139 (2010).","DOI":"10.1002\/14651858.CD000139.pub2"},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00431-009-0961-9","volume":"168","author":"Z Kassim","year":"2009","unstructured":"Kassim, Z., Greenough, A. & Rafferty, G. F. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur. J. Pediatr. 168, 1491\u20131495 (2009).","journal-title":"Eur. J. Pediatr."},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpeds.2015.04.040","volume":"167","author":"JV Kraaijenga","year":"2015","unstructured":"Kraaijenga, J. V., Hutten, G. J., de Jongh, F. H. & van Kaam, A. H. The effect of caffeine on diaphragmatic activity and tidal volume in preterm infants. J. Pediatr. 167, 70\u201375 (2015).","journal-title":"J. Pediatr."},{"key":"89_CR32","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1164\/rccm.201704-0767OC","volume":"196","author":"LW Doyle","year":"2017","unstructured":"Doyle, L. W., Ranganathan, S. & Cheong, J. L. Y. Neonatal caffeine treatment and respiratory function at 11 years in children under 1,251 g at birth. Am. J. Respir. Crit. Care Med. 196, 1318\u20131324 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"89_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/pr.2017.89","volume":"82","author":"XG Jing","year":"2017","unstructured":"Jing, X. G. et al. Caffeine ameliorates hyperoxia-induced lung injury by protecting GCH1 function in neonatal rat pups. Pediatr. Res. 82, 483\u2013489 (2017).","journal-title":"Pediatr. Res."},{"key":"89_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/pr.2017.21","volume":"81","author":"P Rath","year":"2017","unstructured":"Rath, P. et al. Caffeine administration modulates TGF-beta signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia. Pediatr. Res. 81, 795\u2013805 (2017).","journal-title":"Pediatr. Res."},{"key":"89_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bbrc.2014.06.132","volume":"450","author":"KK Tiwari","year":"2014","unstructured":"Tiwari, K. K., Chu, C., Couroucli, X., Moorthy, B. & Lingappan, K. Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro. Biochem. Biophys. Res. Commun. 450, 1345\u20131350 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"89_CR36","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1183\/09031936.00012412","volume":"41","author":"U Weichelt","year":"2013","unstructured":"Weichelt, U. et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur. Respir. J. 41, 966\u2013973 (2013).","journal-title":"Eur. Respir. J."},{"key":"89_CR37","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt, B. et al. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 357, 1893\u20131902 (2007).","journal-title":"N. Engl. J. Med."},{"key":"89_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jpeds.2009.09.069","volume":"156","author":"PG Davis","year":"2010","unstructured":"Davis, P. G. et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J. Pediatr. 156, 382\u2013387 (2010).","journal-title":"J. Pediatr."},{"key":"89_CR39","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1542\/peds.2010-1014","volume":"127","author":"D Dukhovny","year":"2011","unstructured":"Dukhovny, D. et al. Economic evaluation of caffeine for apnea of prematurity. Pediatrics 127, e146\u2013e155 (2011).","journal-title":"Pediatrics"},{"key":"89_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2011.2024","volume":"307","author":"B Schmidt","year":"2012","unstructured":"Schmidt, B. et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 307, 275\u2013282 (2012).","journal-title":"JAMA"},{"key":"89_CR41","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1001\/jama.2009.1708","volume":"302","author":"JF Kieviet de","year":"2009","unstructured":"de Kieviet, J. F., Piek, J. P., Aarnoudse-Moens, C. S. & Oosterlaan, J. Motor development in very preterm and very low-birth-weight children from birth to adolescence: a meta-analysis. JAMA 302, 2235\u20132242 (2009).","journal-title":"JAMA"},{"key":"89_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpeds.2014.04.016","volume":"165","author":"LW Doyle","year":"2014","unstructured":"Doyle, L. W. et al. Reduction in developmental coordination disorder with neonatal caffeine therapy. J. Pediatr. 165, 356\u2013359.e2 (2014).","journal-title":"J. Pediatr."},{"key":"89_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1469-8749.2009.03544.x","volume":"52","author":"J Williams","year":"2010","unstructured":"Williams, J., Lee, K. J. & Anderson, P. J. Prevalence of motor-skill impairment in preterm children who do not develop cerebral palsy: a systematic review. Dev. Med Child Neurol. 52, 232\u2013237 (2010).","journal-title":"Dev. Med Child Neurol."},{"key":"89_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamapediatrics.2017.0238","volume":"171","author":"B Schmidt","year":"2017","unstructured":"Schmidt, B. et al. Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial. JAMA Pediatr. 171, 564\u2013572 (2017).","journal-title":"JAMA Pediatr."},{"key":"89_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","volume":"157","author":"JM Fiore Di","year":"2010","unstructured":"Di Fiore, J. M. et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J. Pediatr. 157, 69\u201373 (2010).","journal-title":"J. Pediatr."},{"key":"89_CR46","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/jp.2017.82","volume":"37","author":"NR Dobson","year":"2017","unstructured":"Dobson, N. R. et al. Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age. J. Perinatol. 37, 1135\u20131140 (2017).","journal-title":"J. Perinatol."},{"key":"89_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000329922","volume":"100","author":"RJ Martin","year":"2011","unstructured":"Martin, R. J., Wang, K., Koroglu, O., Di Fiore, J. & Kc, P. Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 100, 303\u2013310 (2011).","journal-title":"Neonatology"},{"key":"89_CR48","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.4371","volume":"168","author":"LM Rhein","year":"2014","unstructured":"Rhein, L. M. et al. Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial. JAMA Pediatr. 168, 250\u2013257 (2014).","journal-title":"JAMA Pediatr."},{"key":"89_CR49","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/ana.22098","volume":"68","author":"LW Doyle","year":"2010","unstructured":"Doyle, L. W. et al. Caffeine and brain development in very preterm infants. Ann. Neurol. 68, 734\u2013742 (2010).","journal-title":"Ann. Neurol."},{"key":"89_CR50","doi-asserted-by":"publisher","first-page":"e72974","DOI":"10.1371\/journal.pone.0072974","volume":"8","author":"U Pogribna","year":"2013","unstructured":"Pogribna, U. et al. Perinatal clinical antecedents of white matter microstructural abnormalities on diffusion tensor imaging in extremely preterm infants. PloS ONE 8, e72974 (2013).","journal-title":"PloS ONE"},{"key":"89_CR51","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jpeds.2009.10.033","volume":"156","author":"S Supcun","year":"2010","unstructured":"Supcun, S., Kutz, P., Pielemeier, W. & Roll, C. Caffeine increases cerebral cortical activity in preterm infants. J. Pediatr. 156, 490\u2013491 (2010).","journal-title":"J. Pediatr."},{"key":"89_CR52","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ana.21008","volume":"60","author":"SA Back","year":"2006","unstructured":"Back, S. A. et al. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann. Neurol. 60, 696\u2013705 (2006).","journal-title":"Ann. Neurol."},{"key":"89_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2010.05.054","volume":"397","author":"S Connolly","year":"2010","unstructured":"Connolly, S. & Kingsbury, T. J. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem Biophys. Res Commun. 397, 152\u2013156 (2010).","journal-title":"Biochem Biophys. Res Commun."},{"key":"89_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.expneurol.2012.06.028","volume":"237","author":"SP Gaytan","year":"2012","unstructured":"Gaytan, S. P. & Pasaro, R. Neonatal caffeine treatment up-regulates adenosine receptors in brainstem and hypothalamic cardio-respiratory related nuclei of rat pups. Exp. Neurol. 237, 247\u2013259 (2012).","journal-title":"Exp. Neurol."},{"key":"89_CR55","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.1073\/pnas.1931975100","volume":"100","author":"CP Turner","year":"2003","unstructured":"Turner, C. P. et al. A1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proc. Natl Acad. Sci. USA 100, 11718\u201311722 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"89_CR56","doi-asserted-by":"crossref","unstructured":"Winerdal, M., et al. Single dose caffeine protects the neonatal mouse brain against hypoxia ischemia. PLoS ONE 12,\u00a0e0170545 (2017).","DOI":"10.1371\/journal.pone.0170545"},{"key":"89_CR57","doi-asserted-by":"publisher","unstructured":"Endesfelder, S., et al. Neuroprotection by caffeine in hyperoxia-induced neonatal brain injury. Int. J. Mol. Sci. 18,\u00a0(2017) https:\/\/doi.org\/10.3390\/ijms18010187 .","DOI":"10.3390\/ijms18010187"},{"key":"89_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuro.2016.11.012","volume":"58","author":"A Atik","year":"2017","unstructured":"Atik, A. et al. Caffeine for apnea of prematurity: effects on the developing brain. Neurotoxicology 58, 94\u2013102 (2017).","journal-title":"Neurotoxicology"},{"key":"89_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mam.2017.01.001","volume":"55","author":"JF Chen","year":"2017","unstructured":"Chen, J. F. et al. Adenosine receptors and caffeine in retinopathy of prematurity. Mol. Asp. Med. 55, 118\u2013125 (2017).","journal-title":"Mol. Asp. Med."},{"key":"89_CR60","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1096\/fj.201601285R","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Caffeine preferentially protects against oxygen-induced retinopathy. FASEB J. 31, 3334\u20133348 (2017).","journal-title":"FASEB J."},{"key":"89_CR61","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/pr.2016.105","volume":"80","author":"JV Aranda","year":"2016","unstructured":"Aranda, J. V. et al. Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy. Pediatr. Res. 80, 554\u2013565 (2016).","journal-title":"Pediatr. Res."},{"key":"89_CR62","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(76)91090-4","volume":"2","author":"MS Manku","year":"1976","unstructured":"Manku, M. S. & Horrobin, D. F. Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists. Lancet 2, 1115\u20131117 (1976).","journal-title":"Lancet"},{"key":"89_CR63","doi-asserted-by":"crossref","unstructured":"Cox, C., Hashem, N. G., Tebbs, J., Bookstaver, P. B. & Iskersky, V. Evaluation of caffeine and the development of necrotizing enterocolitis. J. Neonatal Perinatal Med. 8, 339\u2013347 (2015).","DOI":"10.3233\/NPM-15814059"},{"key":"89_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2146\/ajhp120457","volume":"70","author":"SJ Lampkin","year":"2013","unstructured":"Lampkin, S. J. et al. Association between caffeine citrate exposure and necrotizing enterocolitis in preterm infants. Am. J. Health-Syst. Pharm. 70, 603\u2013608 (2013).","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"89_CR65","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","volume":"20","author":"A Erenberg","year":"2000","unstructured":"Erenberg, A. et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 20, 644\u2013652 (2000).","journal-title":"Pharmacotherapy"},{"key":"89_CR66","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1542\/peds.109.5.784","volume":"109","author":"C Hoecker","year":"2002","unstructured":"Hoecker, C., Nelle, M., Poeschl, J., Beedgen, B. & Linderkamp, O. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics 109, 784\u2013787 (2002).","journal-title":"Pediatrics"},{"key":"89_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1542\/neo.8-5-e214","volume":"8","author":"G Natarajan","year":"2007","unstructured":"Natarajan, G., Lulic-Botica, M. & Aranda, J. V. Clinical pharmacology of caffeine in the newborn. NeoReviews 8, 213\u2013221 (2007).","journal-title":"NeoReviews"},{"key":"89_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1440-1754.2007.01211.x","volume":"44","author":"AS Soraisham","year":"2008","unstructured":"Soraisham, A. S., Elliott, D. & Amin, H. Effect of single loading dose of intravenous caffeine infusion on superior mesenteric artery blood flow velocities in preterm infants. J. Paediatr. Child Health 44, 119\u2013121 (2008).","journal-title":"J. Paediatr. Child Health"},{"key":"89_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/pr.2016.50","volume":"80","author":"R Chavez-Valdez","year":"2016","unstructured":"Chavez-Valdez, R., Ahlawat, R., Wills-Karp, M. & Gauda, E. B. Mechanisms of modulation of cytokine release by human cord blood monocytes exposed to high concentrations of caffeine. Pediatr. Res. 80, 101\u2013109 (2016).","journal-title":"Pediatr. Res."},{"key":"89_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpeds.2010.06.051","volume":"158","author":"R Chavez Valdez","year":"2011","unstructured":"Chavez Valdez, R. et al. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J. Pediatr. 158, 57\u201364 (2011). 64e51.","journal-title":"J. Pediatr."},{"key":"89_CR71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000363217","volume":"106","author":"OA Koroglu","year":"2014","unstructured":"Koroglu, O. A. et al. Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis. Neonatology 106, 235\u2013240 (2014).","journal-title":"Neonatology"},{"key":"89_CR72","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1164\/rccm.201406-1092OC","volume":"190","author":"CL Marcus","year":"2014","unstructured":"Marcus, C. L. et al. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age. Am. J. Respir. Crit. Care Med. 190, 791\u2013799 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"89_CR73","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1067\/mpd.2002.124383","volume":"140","author":"L Curzi-Dascalova","year":"2002","unstructured":"Curzi-Dascalova, L., Aujard, Y., Gaultier, C. & Rajguru, M. Sleep organization is unaffected by caffeine in premature infants. J. Pediatr. 140, 766\u2013771 (2002).","journal-title":"J. Pediatr."},{"key":"89_CR74","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/jp.2014.60","volume":"34","author":"I Ulanovsky","year":"2014","unstructured":"Ulanovsky, I., Haleluya, N. S., Blazer, S. & Weissman, A. The effects of caffeine on heart rate variability in newborns with apnea of prematurity. J. Perinatol. 34, 620\u2013623 (2014).","journal-title":"J. Perinatol."},{"key":"89_CR75","unstructured":"Crossley, K. J. et al. Effects of caffeine on renal and pulmonary function in preterm newborn lambs. Pediatr. Res. 72, 19\u201325 (2012)."},{"key":"89_CR76","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000243252","volume":"58","author":"I Gillot","year":"1990","unstructured":"Gillot, I., Gouyon, J. B. & Guignard, J. P. Renal effects of caffeine in preterm infants. Biol. Neonate 58, 133\u2013136 (1990).","journal-title":"Biol. Neonate"},{"key":"89_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpeds.2016.01.051","volume":"172","author":"JB Carmody","year":"2016","unstructured":"Carmody, J. B., Harer, M. W., Denotti, A. R., Swanson, J. R. & Charlton, J. R. Caffeine exposure and risk of acute kidney injury in a retrospective cohort of very low birth weight neonates. J. Pediatr. 172, 63 (2016).","journal-title":"J. Pediatr."},{"key":"89_CR78","doi-asserted-by":"publisher","first-page":"F20","DOI":"10.1136\/fn.71.1.F20","volume":"71","author":"YJ Chen","year":"1994","unstructured":"Chen, Y. J., Liou, C. S., Tsai, C. H. & Yeh, T. F. Effect of aminophylline on brain stem auditory evoked potentials in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 71, F20\u2013F23 (1994).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"89_CR79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0883073814538500","volume":"30","author":"NL Maitre","year":"2015","unstructured":"Maitre, N. L. et al. Effects of caffeine treatment for apnea of prematurity on cortical speech-sound differentiation in preterm infants. J. Child Neurol. 30, 307\u2013313 (2015).","journal-title":"J. Child Neurol."},{"key":"89_CR80","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1460-9592.2001.00753.x","volume":"11","author":"E Ergenekon","year":"2001","unstructured":"Ergenekon, E., Dalgic, N., Aksoy, E., Koc, E. & Atalay, Y. Caffeine intoxication in a premature neonate. Paediatr. Anaesth. 11, 737\u2013739 (2001).","journal-title":"Paediatr. Anaesth."},{"key":"89_CR81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pedneo.2016.08.001","volume":"58","author":"S Nakaoka","year":"2017","unstructured":"Nakaoka, S., Kawasaki, Y., Inomata, S., Makimoto, M. & Yoshida, T. Caffeine toxicity in a preterm neonate. Pediatr. Neonatol. 58, 380\u2013381 (2017).","journal-title":"Pediatr. Neonatol."},{"key":"89_CR82","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1440-1754.2003.00207.x","volume":"39","author":"PA Steer","year":"2003","unstructured":"Steer, P. A. et al. Periextubation caffeine in preterm neonates: a randomized dose response trial. J. Paediatr. Child Health 39, 511\u2013515 (2003).","journal-title":"J. Paediatr. Child Health"},{"key":"89_CR83","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3109\/14767058.2014.978757","volume":"28","author":"SM Hassanein","year":"2015","unstructured":"Hassanein, S. M., Gad, G. I., Ismail, R. I. & Diab, M. Effect of caffeine on preterm infants\u2019 cerebral cortical activity: an observational study. J. Matern Fetal Neonatal Med 28, 2090\u20132095 (2015).","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"89_CR84","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3109\/14767058.2015.1041493","volume":"29","author":"AS Gupte","year":"2016","unstructured":"Gupte, A. S., Gupta, D., Ravichandran, S., Ma, M. M. & Chouthai, N. S. Effect of early caffeine on neurodevelopmental outcome of very low-birth weight newborns. J. Matern Fetal Neonatal Med 29, 1233\u20131237 (2016).","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"89_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamapediatrics.2014.2223","volume":"169","author":"A Lodha","year":"2015","unstructured":"Lodha, A. et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 169, 33\u201338 (2015).","journal-title":"JAMA Pediatr."},{"key":"89_CR86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/jp.2012.52","volume":"33","author":"RM Patel","year":"2013","unstructured":"Patel, R. M., Leong, T., Carlton, D. P. & Vyas-Read, S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J. Perinatol. 33, 134\u2013140 (2013).","journal-title":"J. Perinatol."},{"key":"89_CR87","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3109\/14767058.2014.885941","volume":"27","author":"D Taha","year":"2014","unstructured":"Taha, D. et al. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J. Matern. Fetal Neonatal Med. 27, 1698\u20131702 (2014).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"89_CR88","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/bcp.13089","volume":"83","author":"KP Kua","year":"2017","unstructured":"Kua, K. P. & Lee, S. W. H. Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates. Br. J. Clin. Pharmacol. 83, 180\u2013191 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"89_CR89","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3346\/jkms.2015.30.12.1828","volume":"30","author":"HW Park","year":"2015","unstructured":"Park, H. W. et al. Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis. J. Korean Med. Sci. 30, 1828\u20131835 (2015).","journal-title":"J. Korean Med. Sci."},{"key":"89_CR90","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1055\/s-0034-1543981","volume":"32","author":"AC Katheria","year":"2015","unstructured":"Katheria, A. C. et al. A pilot randomized controlled trial of early versus routine caffeine in extremely premature infants. Am. J. Perinatol. 32, 879\u2013885 (2015).","journal-title":"Am. J. Perinatol."},{"key":"89_CR91","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/pr.2017.45","volume":"82","author":"J Dekker","year":"2017","unstructured":"Dekker, J. et al. Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial. Pediatr. Res. 82, 290\u2013296 (2017).","journal-title":"Pediatr. Res."},{"key":"89_CR92","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/pr.2015.72","volume":"78","author":"C McPherson","year":"2015","unstructured":"McPherson, C., Neil, J. J., Tjoeng, T. H., Pineda, R. & Inder, T. E. A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr. Res. 78, 198\u2013204 (2015).","journal-title":"Pediatr. Res."},{"key":"89_CR93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-2006-958163","volume":"24","author":"AE Leon","year":"2007","unstructured":"Leon, A. E., Michienzi, K., Ma, C. X. & Hutchison, A. A. Serum caffeine concentrations in preterm neonates. Am. J. Perinatol. 24, 39\u201347 (2007).","journal-title":"Am. J. Perinatol."},{"key":"89_CR94","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00431-015-2494-8","volume":"174","author":"S Mohammed","year":"2015","unstructured":"Mohammed, S. et al. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur. J. Pediatr. 174, 949\u2013956 (2015).","journal-title":"Eur. J. Pediatr."},{"key":"89_CR95","doi-asserted-by":"publisher","first-page":"F499","DOI":"10.1136\/adc.2002.023432","volume":"89","author":"P Steer","year":"2004","unstructured":"Steer, P. et al. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch. Dis. Child Fetal Neonatal Ed. 89, F499\u2013F503 (2004).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"89_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1754.2010.01943.x","volume":"47","author":"PH Gray","year":"2011","unstructured":"Gray, P. H. et al. Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J. Paediatr. Child Health 47, 167\u2013172 (2011).","journal-title":"J. Paediatr. Child Health"},{"key":"89_CR97","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jcr.2016.0012","volume":"6","author":"ZA Vesoulis","year":"2016","unstructured":"Vesoulis, Z. A., McPherson, C., Neil, J. J., Mathur, A. M. & Inder, T. E. Early high-dose caffeine increases seizure burden in extremely preterm neonates: a preliminary study. J. Caffeine Res. 6, 101\u2013107 (2016).","journal-title":"J. Caffeine Res."},{"key":"89_CR98","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/jp.2014.226","volume":"35","author":"P Alur","year":"2015","unstructured":"Alur, P., Bollampalli, V., Bell, T., Hussain, N. & Liss, J. Serum caffeine concentrations and short-term outcomes in premature infants of<=29 weeks of gestation. J. Perinatol. 35, 434\u2013438 (2015).","journal-title":"J. Perinatol."},{"key":"89_CR99","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1542\/peds.2006-2986","volume":"119","author":"G Natarajan","year":"2007","unstructured":"Natarajan, G., Botica, M. L., Thomas, R. & Aranda, J. V. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 119, 936\u2013940 (2007).","journal-title":"Pediatrics"},{"key":"89_CR100","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00007691-200106000-00011","volume":"23","author":"SN Wildt de","year":"2001","unstructured":"de Wildt, S. N. et al. Use of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther. Drug Monit. 23, 250\u2013254 (2001).","journal-title":"Ther. Drug Monit."},{"key":"89_CR101","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/bcp.13001","volume":"82","author":"NR Dobson","year":"2016","unstructured":"Dobson, N. R. et al. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy. Br. J. Clin. Pharmacol. 82, 754\u2013761 (2016).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"89_CR102","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00007691-199606000-00012","volume":"18","author":"TC Lee","year":"1996","unstructured":"Lee, T. C., Charles, B. G., Steer, P. A. & Flenady, V. J. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity. Ther. Drug Monit. 18, 288\u2013293 (1996).","journal-title":"Ther. Drug Monit."},{"key":"89_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-4450","volume":"137","author":"EC Eichenwald","year":"2016","unstructured":"Eichenwald, E. C. & Newborn, C. F. Apnea of prematurity. Pediatrics 137, 1\u20137 (2016).","journal-title":"Pediatrics"},{"key":"89_CR104","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924\u2013926 (2008).","journal-title":"BMJ"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0089-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0089-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T16:28:55Z","timestamp":1751732935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-018-0089-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1038\/s41390-018-0089-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"1 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}